Federal funding for discovery and development of costly HIV drugs was far more than previously estimated

1 May 2023 - In July 2012, tenofovir disoproxil fumarate-emtricitabine (Truvada) was approved by the FDA to prevent HIV infection.  ...

Read more →

Ethical considerations for the inclusion of patient reported outcomes in clinical research

17 May 2022 - An international consensus Delphi process was developed according to the Enhancing the Quality and Transparency of Health ...

Read more →

Competing with, and learning from, China in the global pharmaceutical innovation race

15 November 2021 - President Joe Biden has promoted investment in technology based industries, including the life sciences, as a strategic ...

Read more →

How much does it cost to research and develop a new drug? A systematic review and assessment

15 October 2021 - Debate over the viability of the current commercial research and development model is on-going.  ...

Read more →

House report: drug companies spent more on buybacks, dividends than research

8 July 2021 - House Democrats on Thursday released a report that found that the 14 leading drug companies paid ...

Read more →

Taxpayers fund research and drug companies make a fortune

24 March 2021 - The pharmaceutical industry doesn’t want things to change, but Americans can have both lower prices and innovation. ...

Read more →

Remdesivir’s hefty price tag ignores NIH investment in its creation

22 October 2020 - Throughout the Democratic presidential primary, candidates cast a spotlight on the broken U.S. health care system ...

Read more →

Financing drug innovation in the US: current framework and emerging challenges

19 August 2020 - The current US drug innovation financing framework rests on the notion that a defined period of marketing ...

Read more →

The world is spending nowhere near enough on a coronavirus vaccine

6 August 2020 - Far better to spend far too much. ...

Read more →

Scientific research on the coronavirus is being released in a torrent

6 May 2020 - Will that change how science is published? ...

Read more →

Scientists rush to find coronavirus cure—but it still isn’t fast enough

6 April 2020 - For drug companies, there is suddenly only one priority: the coronavirus. ...

Read more →

Preserving clinical trial integrity during the coronavirus pandemic

25 March 2020 - Randomised clinical trials provide the highest-quality evidence for identifying therapies to help people attain longer and healthier ...

Read more →

Treating COVID-19—off-label drug use, compassionate use, and randomised clinical trials during pandemics

24 March 2020 - In the 2014 Ebola outbreak, close to 30 000 individuals developed Ebola viral disease, and numerous therapies were ...

Read more →

FDA touts generic drug research in 2019

19 February 2020 - The US FDA on Tuesday released a report detailing the scientific research carried out and funded ...

Read more →

Incidental imaging findings in clinical trials

13 January 2020 - Clinical trial end points are outcome measures used to assess the efficacy and safety of an ...

Read more →